Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT04070755 | Dermal Photo Allergic Skin Reaction | PHASE1 | COMPLETED | 56 | — | — | Sep 21, 2016 | Dec 18, 2016 | Aug 28, 2019 | - | — |
| NCT04052711 | A Randomized, Controlled Study to Evaluate the Sensitizing Potential of FMX-101 in Healthy Volunteers Using a Repeat Insult Patch Test Design | PHASE1 | COMPLETED | 233 | — | — | Sep 8, 2016 | Dec 19, 2016 | Aug 21, 2019 | - | — |
| NCT04064125 | Dermal Cumulative Irritant Patch Study | PHASE1 | COMPLETED | 42 | — | — | Sep 1, 2016 | Oct 28, 2016 | Aug 28, 2019 | - | — |
| NCT04070742 | Dermal Phototoxicity Study | PHASE1 | COMPLETED | 32 | — | — | Aug 17, 2016 | Oct 1, 2016 | Sep 11, 2019 | - | — |
| Arm | Type | Description |
|---|---|---|
| FMX-101 | EXPERIMENTAL | - |
| Name | Type | Description |
|---|---|---|
| FMX-101 | DRUG | - |
| FMX101 | DRUG | - |
Inclusion Criteria: * Healthy male or female who were 18 years of age or older * Had uniformly-colored skin on the lower thoracic area of the back which allowed discernment of erythema, and were Fitzpatrick Skin Types I, II or III Exclusion Criteria: * Had any visible skin disease at the applicat...